This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2009:149:85-105.

doi: 10.1007/978-0-387-98094-2_4.

Biomarker targets and novel therapeutics

Mary Clouser¹, Lisa M Hess, Setsuko K Chambers

Affiliations

PMID: 19763432
DOI: 10.1007/978-0-387-98094-2_4

Review

Biomarker targets and novel therapeutics

Mary Clouser et al. Cancer Treat Res. 2009.

. 2009:149:85-105.

doi: 10.1007/978-0-387-98094-2_4.

Authors

Mary Clouser¹, Lisa M Hess, Setsuko K Chambers

Affiliation

¹ Division of Women's Cancers, Arizona Cancer Center, The University of Arizona, Tucson, AZ, USA.

PMID: 19763432
DOI: 10.1007/978-0-387-98094-2_4

No abstract available

PubMed Disclaimer

Similar articles

Novel therapeutic targets.
Farley J, Birrer MJ. Farley J, et al. Cancer Treat Res. 2009;149:63-84. doi: 10.1007/978-0-387-98094-2_3. Cancer Treat Res. 2009. PMID: 19763431 Review. No abstract available.
New targets for non-small-cell lung cancer therapy.
Alvarez M, Roman E, Santos ES, Raez LE. Alvarez M, et al. Expert Rev Anticancer Ther. 2007 Oct;7(10):1423-37. doi: 10.1586/14737140.7.10.1423. Expert Rev Anticancer Ther. 2007. PMID: 17944567 Review.
Tyrosine-kinases inhibitors in recurrent platinum-resistant ovarian cancer patients.
Marchetti C, Palaia I, De Felice F, Musella A, Donfracesco C, Vertechy L, Romito A, Piacenti I, Musio D, Muzii L, Tombolini V, Benedetti Panici P. Marchetti C, et al. Cancer Treat Rev. 2016 Jan;42:41-6. doi: 10.1016/j.ctrv.2015.10.011. Epub 2015 Nov 10. Cancer Treat Rev. 2016. PMID: 26559739 Review.
Challenges of developing therapeutics that target signal transduction in patients with gynecologic and other malignancies.
Rowinsky EK. Rowinsky EK. J Clin Oncol. 2003 May 15;21(10 Suppl):175s-186s. doi: 10.1200/JCO.2003.01.146. J Clin Oncol. 2003. PMID: 12743132 Review.
Current overview of angiogenesis inhibitors.
Ellis LM. Ellis LM. Clin Adv Hematol Oncol. 2004 Aug;2(8):494-6, 520. Clin Adv Hematol Oncol. 2004. PMID: 16163228 No abstract available.

See all similar articles

Cited by

Enhanced ovarian cancer tumorigenesis and metastasis by the macrophage colony-stimulating factor.
Toy EP, Azodi M, Folk NL, Zito CM, Zeiss CJ, Chambers SK. Toy EP, et al. Neoplasia. 2009 Feb;11(2):136-44. doi: 10.1593/neo.81150. Neoplasia. 2009. PMID: 19177198 Free PMC article.
Development and characterization of a potent immunoconjugate targeting the Fn14 receptor on solid tumor cells.
Zhou H, Marks JW, Hittelman WN, Yagita H, Cheung LH, Rosenblum MG, Winkles JA. Zhou H, et al. Mol Cancer Ther. 2011 Jul;10(7):1276-88. doi: 10.1158/1535-7163.MCT-11-0161. Epub 2011 May 17. Mol Cancer Ther. 2011. PMID: 21586630 Free PMC article.
Role of CSF-1 in progression of epithelial ovarian cancer.
Chambers SK. Chambers SK. Future Oncol. 2009 Nov;5(9):1429-40. doi: 10.2217/fon.09.103. Future Oncol. 2009. PMID: 19903070 Free PMC article. Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information